Epigenomics of Hypertension

Seminars in Nephrology

Volumn 33, Issue 4, 2013, Pages 392-399

  Liang, Mingyu ^a   Cowley, Allen W ^a   Mattson, David L ^a   Kotchen, Theodore A ^a   Liu, Yong ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Blood pressure; DNA methylation; Epigenetics; Histone modification; Kidney

Indexed keywords

UNTRANSLATED RNA;

ARTICLE; BLOOD PRESSURE REGULATION; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; WNK4 GENE;

BLOOD PRESSURE; DNA METHYLATION; EPIGENETICS; HISTONE MODIFICATION; KIDNEY;

ANIMALS; EPIGENOMICS; HUMANS; HYPERTENSION; KIDNEY;

EID: 84883497015     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2013.05.011     Document Type: Article

References (77)

1. Bock C., Tomazou E.M., Brinkman A.B., Müller F., Simmer F., Gu H., et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 2010, 28:1106-1114.
2. Laird P.W. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 2010, 11:191-203.
3. Ozsolak F., Milos P.M. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet 2011, 12:87-98.
4. Park P.J. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 2009, 10:669-680.
5. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
6. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev 2011, 25:1010-1022.
7. Gu H., Smith Z.D., Bock C., Boyle P., Gnirke A., Meissner A. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protoc 2011, 6:468-481.
8. Branco M.R., Ficz G., Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 2011, 13:7-13.
9. Song C.X., Yi C., He C. Mapping recently identified nucleotide variants in the genome and transcriptome. Nat Biotechnol 2012, 30:1107-1116.
10. Booth M.J., Branco M.R., Ficz G., et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 2012, 336:934-937.
11. Yu M., Hon G.C., Szulwach K.E., et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012, 149:1368-1380.
12. Tian Z., Tolić N., Zhao R., Moore R.J., Hengel S.M., Robinson E.W., et al. Enhanced top-down characterization of histone post-translational modifications. Genome Biol 2012, 13:R86.
13. Zentner G.E., Henikoff S. Surveying the epigenomic landscape, one base at a time. Genome Biol 2012, 13:250.
14. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009, 10:155-159.
15. Zaratiegui M, Martienssen RA. SnapShot: small RNA-mediated epigenetic modifications. Cell. 2012;151:456-6.e1.
16. Guttman M., Amit I., Garber M., French C., Lin M.F., Feldser D., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227.
17. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
18. Pauli A., Valen E., Lin M.F., Garber M., Vastenhouw N.L., Levin J.Z., et al. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res 2012, 22:577-591.
19. Rakyan V.K., Down T.A., Balding D.J., Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011, 12:529-541.
20. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010, 303:2043-2050.
21. Heidenreich P.A., Trogdon J.G., Khavjou O.A., Butler J., Dracup K., Ezekowitz M.D., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123:933-944.
22. Kotchen T.A. The search for strategies to control hypertension. Circulation 2010, 122:1141-1143.
23. Egan B.M., Zhao Y., Axon R.N., Brzezinski W.A., Ferdinand K.C. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 2011, 124:1046-1058.
24. Cowley A.W. Long-term control of arterial blood pressure. Physiol Rev 1992, 72:231-300.
25. Cowley A.W., Roman R.J. The role of the kidney in hypertension. JAMA 1996, 275:1581-1589.
26. Guyton A.C. Blood pressure control--special role of the kidneys and body fluids. Science 1991, 252:1813-1816.
27. Lifton R.P., Gharavi A.G., Geller D.S. Molecular mechanisms of human hypertension. Cell 2001, 104:545-556.
28. Liang M., Cowley A.W., Greene A.S. High throughput gene expression profiling: a molecular approach to integrative physiology. J Physiol 2004, 554:22-30.
29. Liang M., Cowley A.W., Hessner M.J., Lazar J., Basile D.P., Pietrusz J.L. Transcriptome analysis and kidney research: toward systems biology. Kidney Int 2005, 67:2114-2122.
30. Malek R.L., Wang H.Y., Kwitek A.E., Greene A.S., Bhagabati N., Borchardt G., et al. Physiogenomic resources for rat models of heart, lung and blood disorders. Nat Genet 2006, 38:234-239.
31. Marques F.Z., Campain A.E., Yang Y.H., Morris B.J. Meta-analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension. Hypertension 2010, 56:319-324.
32. Sullivan J.M., Prewitt R.L., Ratts T.E. Sodium sensitivity in normotensive and borderline hypertensive humans. Am J Med Sci 1988, 295:370-377.
33. Weinberger M.H. Salt sensitivity of blood pressure in humans. Hypertension 1996, 27:481-490.
34. Cowley A.W. The genetic dissection of essential hypertension. Nat Rev Genet 2006, 7:829-840.
35. Rapp J.P. Dahl salt-susceptible and salt-resistant rats. Hypertension 1982, 4:753-763.
36. Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991;17 Suppl:I52-8.
37. Liang M., Yuan B., Rute E., Greene A.S., Zou A.-P., Soares P., et al. Renal medullary genes in salt-sensitive hypertension: a chromosomal substitution and cDNA microarray study. Physiol Genomics 2002, 8:139-149.
38. Liang M., Yuan B., Rute E., Greene A.S., Olivier M., Cowley A.W. Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics 2003, 12:229-237.
39. Liang M., Lee N.H., Wang H., Greene A.S., Kwitek A.E., Kaldunski M.L., et al. Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats. Physiol Genomics 2008, 34:54-64.
40. Liu Y., Taylor N.E., Lu L., Usa K., Cowley A.W., Ferreri N.R., et al. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 2010, 55:974-982.
41. Lu L., Li P., Yang C., Kurth T., Misale M., Skelton M.M., et al. Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol Genomics 2010, 41:63-70.
42. Mori T., Polichnowski A., Glocka P., Kaldunski M., Ohsaki Y., Liang M., et al. High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J Am Soc Nephrol 2008, 19:1472-1482.
43. Tian Z., Greene A.S., Usa K., Matus I.R., Bauwens J., Pietrusz J.L., et al. Renal regional proteomes in young Dahl salt-sensitive rats. Hypertension 2008, 51:899-904.
44. Yang C., Stingo F.C., Ahn K.W., Liu P., Vannucci M., Laud P.W., et al. Increased proliferative cells in the medullary thick ascending limb of the loop of Henle in the Dahl salt-sensitive rat. Hypertension 2013, 61:208-215.
45. Zheleznova N.N., Yang C., Ryan R.P., Halligan B.D., Liang M., Greene A.S., et al. Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat. Physiol Genomics 2012, 44:829-842.
46. Cowley A.W., Liang M., Roman R.J., Greene A.S., Jacob H.J. Consomic rat model systems for physiological genomics. Acta Physiol Scand 2004, 181:585-592.
47. Moreno C., Kaldunski M.L., Wang T., Roman R.J., Greene A.S., Lazar J., et al. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics 2007, 31:228-235.
48. Liu Y., Singh R.J., Usa K., Netzel B.C., Liang M. Renal medullary 11β-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension. Physiol Genomics 2008, 36:52-58.
49. Fornage M., Doris P.A. Genomics and epigenomics of hypertension. Curr Opin Mol Ther 2006, 8:206-214.
50. Wang X., Falkner B., Zhu H., Shi H., Su S., Xu X., et al. A genome-wide methylation study on essential hypertension in young African American males. PLoS One 2013, 8:e53938.
51. Mattson D.L., Kunert M.P., Kaldunski M.L., Greene A.S., Roman R.J., Jacob H.J., et al. Influence of diet and genetics on hypertension and renal disease in Dahl salt-sensitive rats. Physiol Genomics 2004, 16:194-203.
52. Mattson D.L., Meister C.J., Marcelle M.L. Dietary protein source determines the degree of hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 2005, 45:736-741.
53. Kriegel A.J., Mladinov D., Liang M. Translational study of MicroRNAs and its application in kidney disease and hypertension research. Clin Sci (Lond) 2012, 122:439-447.
54. Liang M., Liu Y., Mladinov D., Cowley A.W., Trivedi H., Fang Y., et al. MicroRNA: a new frontier in kidney and blood pressure research (invited review). Am J Physiol Renal Physiol 2009, 297:F553-F558.
55. Frey F.J. Methylation of CpG islands: potential relevance for hypertension and kidney diseases. Nephrol Dial Transplant 2005, 20:868-869.
56. Millis R.M. Epigenetics and hypertension. Curr Hypertens Rep 2011, 13:21-28.
57. Zandi-Nejad K., Luyckx V.A., Brenner B.M. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006, 47:502-508.
58. Pham T.D., MacLennan N.K., Chiu C.T., Laksana G.S., Hsu J.L., Lane R.H. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 2003, 285:R962-R970.
59. Wyrwoll C.S., Mark P.J., Waddell B.J. Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system. Hypertension 2007, 50:579-584.
60. Liu Y., Mladinov D., Pietrusz J.L., Usa K., Liang M. Glucocorticoid response elements and 11β-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res 2009, 81:140-147.
61. Mu S., Shimosawa T., Ogura S., Wang H., Uetake Y., Kawakami-Mori F., et al. Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med 2011, 17:573-580.
62. Alikhani-Koopaei R., Fouladkou F., Frey F.J., Frey B.M. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 2004, 114:1146-1157.
63. Baserga M., Kaur R., Hale M.A., Bares A., Yu X., Callaway C.W., et al. Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11beta-hydroxysteroid dehydrogenase type 2 in a sex-specific manner. Am J Physiol Regul Integr Comp Physiol 2010, 299:R334-R342.
64. Zhang D., Yu Z.Y., Cruz P., Kong Q., Li S., Kone B.C. Epigenetics and the control of epithelial sodium channel expression in collecting duct. Kidney Int 2009, 75:260-267.
65. Lee H.A., Cho H.M., Lee D.Y., Kim K.C., Han H.S., Kim I.K. Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. Hypertension 2012, 59:621-626.
66. Rivière G., Lienhard D., Andrieu T., Vieau D., Frey B.M., Frey F.J. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 2011, 6:478-489.
67. Bogdarina I., Welham S., King P.J., Burns S.P., Clark A.J. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res 2007, 100:520-526.
68. Li F., Papworth M., Minczuk M., Rohde C., Zhang Y., Ragozin S., et al. Chimeric DNA methyltransferases target DNA methylation to specific DNA sequences and repress expression of target genes. Nucleic Acids Res 2007, 35:100-112.
69. Nomura W., Barbas C.F. In vivo site-specific DNA methylation with a designed sequence-enabled DNA methylase. J Am Chem Soc 2007, 129:8676-8677.
70. Xu G.L., Bestor T.H. Cytosine methylation targeted to pre-determined sequences. Nat Genet 1997, 17:376-378.
71. Cowley A.W., Nadeau J.H., Baccarelli A., Berecek K., Fornage M., Gibbons G.H., et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension 2012, 59:899-905.
72. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science 2001, 293:1089-1093.
73. Guibert S., Forné T., Weber M. Global profiling of DNA methylation erasure in mouse primordial germ cells. Genome Res 2012, 22:633-641.
74. Hackett J.A., Sengupta R., Zylicz J.J., Murakami K., Lee C., Down T.A., et al. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 2013, 339:448-452.
75. Smith Z.D., Chan M.M., Mikkelsen T.S., Gu H., Gnirke A., Regev A., et al. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 2012, 484:339-344.
76. Carone B.R., Fauquier L., Habib N., Shea J.M., Hart C.E., Li R., et al. Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 2010, 143:1084-1096.
77. Rassoulzadegan M., Grandjean V., Gounon P., Vincent S., Gillot I., Cuzin F. RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature 2006, 441:469-474.